181 related articles for article (PubMed ID: 25123613)
1. Daily peer review of abnormal cervical smears in the assessment of individual practice as an additional method of internal quality control.
Confortini M; Di Stefano C; Biggeri A; Bulgaresi P; Di Claudio G; Grisotto L; Maddau C; Matucci M; Petreschi C; Troni GM; Turco P; Foxi P
Cytopathology; 2016 Feb; 27(1):35-42. PubMed ID: 25123613
[TBL] [Abstract][Full Text] [Related]
2. The impact of blind peer review (team reading) of equivocal/abnormal Papanicolaou smears on inter-reader agreement.
Placidi A; Giorgi Rossi P
Cytopathology; 2019 Jan; 30(1):105-108. PubMed ID: 30276905
[TBL] [Abstract][Full Text] [Related]
3. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
[TBL] [Abstract][Full Text] [Related]
4. The use of digital images to evaluate the interobserver agreement on cervical smear readings in Italian cervical cancer screening.
Tinacci G; Biggeri A; Pellegrini A; Cariaggi MP; Schiboni ML; Confortini M
Cytopathology; 2011 Apr; 22(2):75-81. PubMed ID: 20482719
[TBL] [Abstract][Full Text] [Related]
5. A quality control system involving peer review of abnormal cervical smears.
Palli D; Confortini M; Biggeri A; Russo A; Cariaggi P; Carozzi F; Minuti PA
Cytopathology; 1993; 4(1):17-25. PubMed ID: 8453014
[TBL] [Abstract][Full Text] [Related]
6. Systemic cervical cytology training and quality control programs can improve the interpretation of Papanicolaou tests.
Xie F; Li Z; Zhang L; Zhang H; Qi D; Zhao D; Zhang X; Wang X; Zhao C
J Am Soc Cytopathol; 2019; 8(1):27-33. PubMed ID: 30929756
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
Fabbris E; Bucchi L; Folicaldi S; Amadori A; Ghidoni D; Medri M; Bondi A
Pathologica; 1998 Apr; 90(2):127-32. PubMed ID: 9619055
[TBL] [Abstract][Full Text] [Related]
8. Impact of Implementing 100% Rapid Review as a Quality Control Tool in Cervical Cytology.
Magalhães JC; Ázara CZS; Tavares SBDN; Manrique EJC; Amaral RG
Acta Cytol; 2018; 62(2):115-120. PubMed ID: 29597202
[TBL] [Abstract][Full Text] [Related]
9. Consistency of cytology diagnosis for cervical cancer between two laboratories.
Sriamporn S; Kritpetcharat O; Nieminen P; Suwanrungraung K; Kamsa-ard S; Parkin DM
Asian Pac J Cancer Prev; 2005; 6(2):208-12. PubMed ID: 16101335
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the PAPNET cytologic screening system for quality control of cervical smears.
Koss LG; Lin E; Schreiber K; Elgert P; Mango L
Am J Clin Pathol; 1994 Feb; 101(2):220-9. PubMed ID: 8116579
[TBL] [Abstract][Full Text] [Related]
11. Implementation of pre-captured videos for remote diagnosis of cervical cytology specimens.
Archondakis S; Roma M; Kaladelfou E
Cytopathology; 2021 May; 32(3):338-343. PubMed ID: 33368677
[TBL] [Abstract][Full Text] [Related]
12. Does 100% Rapid Review Improve Cervical Cancer Screening?
Queiroz Filho J; Eleutério J; Ney Cobucci R; de Oliveira Crispim JC; Giraldo PC; Gonçalves AK
Acta Cytol; 2018; 62(3):209-214. PubMed ID: 29788025
[TBL] [Abstract][Full Text] [Related]
13. External quality control of cervical cytopathology: interlaboratory variability.
Azara CZ; Manrique EJ; Alves de Souza NL; Rodrigues AR; Tavares SB; Amaral RG
Acta Cytol; 2013; 57(6):585-90. PubMed ID: 24107687
[TBL] [Abstract][Full Text] [Related]
14. Rapid prescreen of cervical liquid-based cytology preparations: results of a study in an academic medical center.
Frable WJ; Pedigo MA; Powers CN; Yarrell C; Ortiz B; Clark ME; Ebron T
Diagn Cytopathol; 2012 Aug; 40(8):691-7. PubMed ID: 22807384
[TBL] [Abstract][Full Text] [Related]
15. Intralaboratory reproducibility of cervical cytology diagnoses in the external quality assurance scheme of the Emilia-Romagna region of Italy.
Sama D; Cotignoli T; Guerrini L; Maioli P; Sintoni C; Bucchi L
Gynecol Oncol; 1996 Mar; 60(3):404-8. PubMed ID: 8774647
[TBL] [Abstract][Full Text] [Related]
16. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
17. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
Castle PE; Reid J; Dockter J; Getman D
J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
[TBL] [Abstract][Full Text] [Related]
18. Regulatory closure of cervical cytology laboratories: recommendations for a public health response.
MMWR Recomm Rep; 1997 Dec; 46(RR-17):1-19. PubMed ID: 9409538
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of cervical cytopathology following an intervention by an external quality control laboratory.
Ázara CZ; Manrique EJ; Tavares SB; Alves de Souza NL; Magalhães JC; Amaral RG
Diagn Cytopathol; 2016 Apr; 44(4):305-10. PubMed ID: 26848707
[TBL] [Abstract][Full Text] [Related]
20. [External quality control for cervical cytology exams performed in the Brazilian Public Health System of Mato Grosso do Sul State].
de Freitas HG; Thuler LC
Rev Bras Ginecol Obstet; 2012 Aug; 34(8):351-6. PubMed ID: 23080277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
